Ask-the-Expert Online Conference
- Question from Amma: Does anyone have any input on taking Arimidex longer than the five-year mark? I took tamoxifen for two years and Arimidex for three, and my doctor says continuing might be beneficial.
- Answers - Lynn Hartmann That's a good question, and we're looking for answers to that with ongoing clinical trials. The clinical trial that looked at Femara (chemical name: letrozole), an aromatase inhibitor similar to Arimidex (chemical name: anastrozole) or Aromasin (chemical name: exemestane), examined five years of Femara after five years of tamoxifen. Now it is looking at five additional years of Femara (a total of 10 years) compared to placebo. Your question is a good one, but I don't know a specific answer at this time. And most physicians are stopping after two to three years of tamoxifen plus two to three years of an aromatase inhibitor.
This Ask-the-Expert Online Conference called Risk Reduction featured Beth Baughman DuPree, M.D., F.A.C.S. and Lynn Hartmann answering your questions about breast cancer risk factors and ways to lower your risk.
Editor's Note: This conference took place in February 2006.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.